Macrogol

Macrogol, the active ingredient in this product, is an osmotic laxative presented as an oral formulation for oral use. It works by retaining water in the intestinal lumen, thereby softening stool and facilitating bowel movements, and is indicated for the treatment of constipation and for bowel preparation prior to diagnostic procedures in both adult and pediatric patients under medical supervision.

GNH USA supplies Macrogol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, including academic medical centres and community health providers.

Macrogol is an osmotic laxative used to manage conditions related to impaired bowel motility. - Constipation: relieves infrequent or difficult stool passage by softening stool and increasing frequency. - Bowel preparation for diagnostic procedures: clears the intestinal tract to improve visualization during colonoscopy, sigmoidoscopy, or radiologic studies. - Pre‑operative bowel cleansing: reduces fecal bulk before surgical interventions involving the gastrointestinal tract.

Macrogol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating - Flatulence - Nausea - Diarrhea

Serious or Rare Side Effects: - Severe electrolyte imbalance - Acute renal failure - Allergic reaction (rash, angioedema)

Before prescribing Macrogol, clinicians should consider several safety aspects. - Renal function: assess baseline renal status, especially in patients with chronic kidney disease. - Electrolyte status: monitor serum sodium and potassium when used for prolonged periods. - Dehydration: ensure adequate fluid intake to prevent excessive fluid loss. - Pregnancy and lactation: use only if clearly needed and prescribed by a healthcare professional. - Age considerations: dose adjustments may be required for pediatric or elderly patients. - Store below 25°C: keep in the original container, protect from moisture.

Macrogol can interact with other medications that affect fluid or electrolyte balance.

Major Interactions (Avoid): - Concomitant use with other potent osmotic laxatives (e.g., sodium phosphate) – risk of severe fluid loss. - Concurrent high‑dose diuretics – may exacerbate electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium – may increase osmotic load. - Mineral supplements (potassium, calcium) – monitor electrolytes. - NSAIDs – may affect renal function. - ACE inhibitors – monitor renal function and electrolytes.